Summit Therapeutics (SMMT) Cash from Investing Activities (QoQ) (2017 - 2026)
Summit Therapeutics (SMMT) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Summit Therapeutics | 10.29 Bn | 9.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93,753.78% |
| Mar 31, 2026 | 99.95% |
| Dec 31, 2025 | -683,219.72% |
| Sep 30, 2025 | -100.05% |
| Jun 30, 2025 | -5.81% |
| Mar 31, 2025 | 91.79% |
| Dec 31, 2024 | 176.86% |
| Sep 30, 2024 | 45.71% |
| Jun 30, 2024 | -1,106.89% |
| Mar 31, 2024 | -67.19% |
| Dec 31, 2023 | 1,837.46% |
| Sep 30, 2023 | -1,784.06% |
| Jun 30, 2023 | 100.03% |
| Mar 31, 2023 | -6,450,730.00% |
| Dec 31, 2022 | -50.00% |
| Sep 30, 2022 | 106.83% |
| Jun 30, 2022 | 18.84% |
| Mar 31, 2022 | -200.83% |
| Dec 31, 2021 | -3,100.00% |
| Sep 30, 2021 | 102.65% |